A re-examination of the impact of refere
β
Paul Grootendorst; David Stewart
π
Article
π
2006
π
John Wiley and Sons
π
English
β 196 KB
π 1 views
## Abstract Reference pricing (RP) limits drug plan reimbursement of interchangeable medicines to a reference price, which is typically equal to the price of the lowestβcost interchangeable drug; any cost above that is borne by the patient. Much of the evidence of the effects of RP comes from βbefo